These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

122 related articles for article (PubMed ID: 11697882)

  • 1. Intracellular targeting of proteins by sumoylation.
    Wilson VG; Rangasamy D
    Exp Cell Res; 2001 Nov; 271(1):57-65. PubMed ID: 11697882
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Viral interaction with the host cell sumoylation system.
    Wilson VG; Rangasamy D
    Virus Res; 2001 Dec; 81(1-2):17-27. PubMed ID: 11682121
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Ubiquitin-related modifier SUMO1 and nucleocytoplasmic transport.
    Pichler A; Melchior F
    Traffic; 2002 Jun; 3(6):381-7. PubMed ID: 12010456
    [TBL] [Abstract][Full Text] [Related]  

  • 4. E1B-55K-Mediated Regulation of RNF4 SUMO-Targeted Ubiquitin Ligase Promotes Human Adenovirus Gene Expression.
    Müncheberg S; Hay RT; Ip WH; Meyer T; Weiß C; Brenke J; Masser S; Hadian K; Dobner T; Schreiner S
    J Virol; 2018 Jul; 92(13):. PubMed ID: 29695423
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The ND10 Component Promyelocytic Leukemia Protein Acts as an E3 Ligase for SUMOylation of the Major Immediate Early Protein IE1 of Human Cytomegalovirus.
    Reuter N; Schilling EM; Scherer M; Müller R; Stamminger T
    J Virol; 2017 May; 91(10):. PubMed ID: 28250117
    [TBL] [Abstract][Full Text] [Related]  

  • 6. SUMO wrestling with specificity.
    VanDemark AP; Hill CP
    Structure; 2002 Mar; 10(3):281-2. PubMed ID: 12005425
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The DNA topoisomerase I binding protein topors as a novel cellular target for SUMO-1 modification: characterization of domains necessary for subcellular localization and sumolation.
    Weger S; Hammer E; Engstler M
    Exp Cell Res; 2003 Oct; 290(1):13-27. PubMed ID: 14516784
    [TBL] [Abstract][Full Text] [Related]  

  • 8. SIM-dependent enhancement of substrate-specific SUMOylation by a ubiquitin ligase in vitro.
    Parker JL; Ulrich HD
    Biochem J; 2014 Feb; 457(3):435-40. PubMed ID: 24224485
    [TBL] [Abstract][Full Text] [Related]  

  • 9. SUMO/sentrin: protein modifiers regulating important cellular functions.
    Kretz-Remy C; Tanguay RM
    Biochem Cell Biol; 1999; 77(4):299-309. PubMed ID: 10546893
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Role of an N-terminal site of Ubc9 in SUMO-1, -2, and -3 binding and conjugation.
    Tatham MH; Kim S; Yu B; Jaffray E; Song J; Zheng J; Rodriguez MS; Hay RT; Chen Y
    Biochemistry; 2003 Aug; 42(33):9959-69. PubMed ID: 12924945
    [TBL] [Abstract][Full Text] [Related]  

  • 11. An extended consensus motif enhances the specificity of substrate modification by SUMO.
    Yang SH; Galanis A; Witty J; Sharrocks AD
    EMBO J; 2006 Nov; 25(21):5083-93. PubMed ID: 17036045
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The nucleoporin RanBP2 has SUMO1 E3 ligase activity.
    Pichler A; Gast A; Seeler JS; Dejean A; Melchior F
    Cell; 2002 Jan; 108(1):109-20. PubMed ID: 11792325
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Ubc9 fusion-directed SUMOylation (UFDS): a method to analyze function of protein SUMOylation.
    Jakobs A; Koehnke J; Himstedt F; Funk M; Korn B; Gaestel M; Niedenthal R
    Nat Methods; 2007 Mar; 4(3):245-50. PubMed ID: 17277783
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Members of the PIAS family act as SUMO ligases for c-Jun and p53 and repress p53 activity.
    Schmidt D; Müller S
    Proc Natl Acad Sci U S A; 2002 Mar; 99(5):2872-7. PubMed ID: 11867732
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Covalent modification of the transactivator protein IE2-p86 of human cytomegalovirus by conjugation to the ubiquitin-homologous proteins SUMO-1 and hSMT3b.
    Hofmann H; Flöss S; Stamminger T
    J Virol; 2000 Mar; 74(6):2510-24. PubMed ID: 10684265
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Regulation of the Ets-1 transcription factor by sumoylation and ubiquitinylation.
    Ji Z; Degerny C; Vintonenko N; Deheuninck J; Foveau B; Leroy C; Coll J; Tulasne D; Baert JL; Fafeur V
    Oncogene; 2007 Jan; 26(3):395-406. PubMed ID: 16862185
    [TBL] [Abstract][Full Text] [Related]  

  • 17. PML IV/ARF interaction enhances p53 SUMO-1 conjugation, activation, and senescence.
    Ivanschitz L; Takahashi Y; Jollivet F; Ayrault O; Le Bras M; de Thé H
    Proc Natl Acad Sci U S A; 2015 Nov; 112(46):14278-83. PubMed ID: 26578773
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Gam1 and the SUMO pathway.
    Boggio R; Chiocca S
    Cell Cycle; 2005 Apr; 4(4):533-5. PubMed ID: 15876861
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Role for SUMO modification in facilitating transcriptional repression by BKLF.
    Perdomo J; Verger A; Turner J; Crossley M
    Mol Cell Biol; 2005 Feb; 25(4):1549-59. PubMed ID: 15684403
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Reconstitution of the Recombinant RanBP2 SUMO E3 Ligase Complex.
    Ritterhoff T; Das H; Hao Y; Sakin V; Flotho A; Werner A; Melchior F
    Methods Mol Biol; 2016; 1475():41-54. PubMed ID: 27631796
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.